These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 35738036

  • 1. Impact of revised EORTC/MSGERC 2020 criteria on diagnosis and prognosis of invasive pulmonary aspergillosis in patients with hematological malignancies undergoing bronchoscopy.
    Acet-Öztürk NA, Ömer-Topçu D, Vurat-Acar K, Aydın-Güçlü Ö, Pınar İE, Demirdöğen E, Görek-Dilektaşlı A, Kazak E, Özkocaman V, Ursavas A, Akalın H, Özkalemkaş F, Ener B, Ali R.
    J Mycol Med; 2022 Nov; 32(4):101304. PubMed ID: 35738036
    [Abstract] [Full Text] [Related]

  • 2. The impact of the updated EORTC/MSG criteria on the classification of hematological patients with suspected invasive pulmonary aspergillosis.
    Lamberink H, Wagemakers A, Sigaloff KCE, van Houdt R, de Jonge NA, van Dijk K.
    Clin Microbiol Infect; 2022 Aug; 28(8):1120-1125. PubMed ID: 35248746
    [Abstract] [Full Text] [Related]

  • 3. [Evaluation of risk factors for invasive pulmonary aspergillosis and detection of diagnostic values of galactomannan and PCR methods in bronchoalveolar lavage samples from non-neutropenic intensive care unit patients].
    Özger S, Hızel K, Kalkancı A, Aydoğdu M, Civil F, Dizbay M, Gürsel G.
    Mikrobiyol Bul; 2015 Oct; 49(4):565-75. PubMed ID: 26649414
    [Abstract] [Full Text] [Related]

  • 4. Retrospective Multicenter Evaluation of the VirClia Galactomannan Antigen Assay for the Diagnosis of Pulmonary Aspergillosis with Bronchoalveolar Lavage Fluid Samples from Patients with Hematological Disease.
    Buil JB, Huygens S, Dunbar A, Schauwvlieghe A, Reynders M, Langerak D, van Dijk K, Bruns A, Haas PJ, Postma DF, Biemond B, Delma FZ, de Kort E, Melchers WJG, Verweij PE, Rijnders B.
    J Clin Microbiol; 2023 May 23; 61(5):e0004423. PubMed ID: 37097150
    [Abstract] [Full Text] [Related]

  • 5. Galactomannan in bronchoalveolar lavage for diagnosing invasive fungal disease.
    Affolter K, Tamm M, Jahn K, Halter J, Passweg J, Hirsch HH, Stolz D.
    Am J Respir Crit Care Med; 2014 Aug 01; 190(3):309-17. PubMed ID: 25007380
    [Abstract] [Full Text] [Related]

  • 6. Aspergillus-Specific Lateral-Flow Device and Real-Time PCR Testing of Bronchoalveolar Lavage Fluid: a Combination Biomarker Approach for Clinical Diagnosis of Invasive Pulmonary Aspergillosis.
    Johnson GL, Sarker SJ, Nannini F, Ferrini A, Taylor E, Lass-Flörl C, Mutschlechner W, Bustin SA, Agrawal SG.
    J Clin Microbiol; 2015 Jul 01; 53(7):2103-8. PubMed ID: 25903568
    [Abstract] [Full Text] [Related]

  • 7. Diagnostic role of polymerase chain reaction in bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in immunocompromised patients - A retrospective cohort study.
    Hardak E, Fuchs E, Leskes H, Geffen Y, Zuckerman T, Oren I.
    Int J Infect Dis; 2019 Jun 01; 83():20-25. PubMed ID: 30926540
    [Abstract] [Full Text] [Related]

  • 8. Diagnosing Invasive Pulmonary Aspergillosis in Hematology Patients: a Retrospective Multicenter Evaluation of a Novel Lateral Flow Device.
    Mercier T, Schauwvlieghe A, de Kort E, Dunbar A, Reynders M, Guldentops E, Rijnders B, Verweij PE, Lagrou K, Maertens J.
    J Clin Microbiol; 2019 Apr 01; 57(4):. PubMed ID: 30651395
    [Abstract] [Full Text] [Related]

  • 9. Performance of the galactomannan test for the diagnosis of invasive pulmonary aspergillosis using non-invasive proximal airway samples.
    Chun JY, Jeong SJ, Kim S, Choi S, Lee JH, Chung HS, Park S, Lee H, Kim HY, Hwangbo B, Choi YJ.
    J Infect; 2024 Jun 01; 88(6):106159. PubMed ID: 38641139
    [Abstract] [Full Text] [Related]

  • 10. A Prospective Multicenter Cohort Surveillance Study of Invasive Aspergillosis in Patients with Hematologic Malignancies in Greece: Impact of the Revised EORTC/MSGERC 2020 Criteria.
    Siopi M, Karakatsanis S, Roumpakis C, Korantanis K, Sambatakou H, Sipsas NV, Tsirigotis P, Pagoni M, Meletiadis J.
    J Fungi (Basel); 2021 Jan 05; 7(1):. PubMed ID: 33466525
    [Abstract] [Full Text] [Related]

  • 11. Diagnosis of invasive pulmonary aspergillosis in children with bronchoalveolar lavage galactomannan.
    de Mol M, de Jongste JC, van Westreenen M, Merkus PJ, de Vries AH, Hop WC, Warris A, Janssens HM.
    Pediatr Pulmonol; 2013 Aug 05; 48(8):789-96. PubMed ID: 22949309
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic Efficacy of Aspergillus Galactomannan Lateral Flow Assay in Patients with Hematological Malignancies: A Prospective Multicenter Study.
    Alhan O, Saba R, Akalin EH, Ener B, Ture Yuce Z, Deveci B, Guncu MM, Kahveci HN, Yilmaz AF, Odabasi Z.
    Mycopathologia; 2023 Oct 05; 188(5):643-653. PubMed ID: 37273172
    [Abstract] [Full Text] [Related]

  • 13. Bronchoalveolar galactomannan in invasive pulmonary aspergillosis: a prospective study in pediatric patients.
    Mohammadi S, Khalilzadeh S, Goudarzipour K, Hassanzad M, Mahdaviani A, Aarabi N, Pourabdollah M, Sigari N.
    Med Mycol; 2015 Sep 05; 53(7):709-16. PubMed ID: 26229150
    [Abstract] [Full Text] [Related]

  • 14. Detection of invasive pulmonary aspergillosis in haematological malignancy patients by using lateral-flow technology.
    Thornton C, Johnson G, Agrawal S.
    J Vis Exp; 2012 Mar 22; (61):. PubMed ID: 22473419
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic accuracy of the Aspergillus-specific bronchoalveolar lavage lateral-flow assay in haematological malignancy patients.
    Prattes J, Lackner M, Eigl S, Reischies F, Raggam RB, Koidl C, Flick H, Wurm R, Palfner M, Wölfler A, Neumeister P, Thornton CR, Krause R, Lass-Flörl C, Hoenigl M.
    Mycoses; 2015 Aug 22; 58(8):461-9. PubMed ID: 26103209
    [Abstract] [Full Text] [Related]

  • 16. Diagnostic Utility of Galactomannan Enzyme Immunoassay in Invasive Aspergillosis in Pediatric patients with Hematological Malignancy.
    Das S, Capoor MR, Singh A, Agarwal Y.
    Mycopathologia; 2023 Dec 22; 188(6):1055-1063. PubMed ID: 37806994
    [Abstract] [Full Text] [Related]

  • 17. Impact of bronchoalveolar lavage galactomannan on the outcome of patients at risk for invasive pulmonary aspergillosis.
    Danpornprasert P, Foongladda S, Tscheikuna J.
    J Med Assoc Thai; 2010 Jan 22; 93 Suppl 1():S86-93. PubMed ID: 20364562
    [Abstract] [Full Text] [Related]

  • 18. Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies.
    Heng SC, Chen SC, Morrissey CO, Thursky K, Manser RL, De Silva HD, Halliday CL, Seymour JF, Nation RL, Kong DC, Slavin MA.
    Diagn Microbiol Infect Dis; 2014 Jul 22; 79(3):322-7. PubMed ID: 24768294
    [Abstract] [Full Text] [Related]

  • 19. [Comparison of the Results of Galactomannan and Beta Glucan Antigen Tests in the Suspicion of Invasive Pulmonary Aspergillosis].
    Çuhadar T, Kalkancı A, Tunçcan Güzel Ö, Yeğin ZA, Özkurt ZN, Köktürk N, Yağcı M.
    Mikrobiyol Bul; 2023 Apr 22; 57(2):274-282. PubMed ID: 37067211
    [Abstract] [Full Text] [Related]

  • 20. Galactomannan testing of bronchoalveolar lavage fluid is useful for diagnosis of invasive pulmonary aspergillosis in hematology patients.
    Hsu LY, Ding Y, Phua J, Koh LP, Chan DS, Khoo KL, Tambyah PA.
    BMC Infect Dis; 2010 Mar 03; 10():44. PubMed ID: 20199673
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.